FEDERICO CANAVOSIO: Open Payments
NPI 1679721393 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,391 in 60 payments from 20 companies in 2025. Trend: 2023 $1,366 · 2024 $1,564 · 2025 $2,391
Food & beverage: $2,391
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $534 |
| Boston Scientific Corporation | 5 | $342 |
| Novo Nordisk Inc | 8 | $341 |
| Lilly USA, LLC | 6 | $225 |
| Amgen Inc. | 7 | $216 |
| Corcept Therapeutics | 4 | $177 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $87 |
| Edwards Lifesciences Corporation | 1 | $69 |
| Eisai Inc. | 2 | $64 |
| Axsome Therapeutics, Inc. | 2 | $57 |
Products named: WATCHMAN FLX, AIRSUPRA, Ozempic, FARXIGA, MOUNJARO, Korlym, REPATHA, Wegovy.
Industry payments across FL — which companies pay providers there.
